Urgosedin inhibits hypotension, hypoglycemia, and pro-inflammatory mediators induced by lipopolysaccharide

Journal of Cardiovascular Pharmacology

Volumn 44, Issue 3, 2004, Pages 363-371

  Lo, Yi Ching ^a   Wang, Ching Chin ^a   Shen, Kuo Pyng ^a   Wu, Bin Nan ^a   Yu, Kwong Leung ^a   Chen, Ing Jun ^a  

^a KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Cytokine; Hypoglycemia; Hypotension; Inducible nitric oxide synthase; Lipopolysaccharide; Urgosedin

Indexed keywords

ALPHA 1 ADRENERGIC RECEPTOR; ALPHA 2 ADRENERGIC RECEPTOR; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; AUTACOID; BENZENE DERIVATIVE; CLONIDINE; CYTOKINE; GAMMA INTERFERON; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1BETA; INTERLEUKIN 6; KATACALCIN; LIPOPOLYSACCHARIDE; NORADRENALIN; PIPERAZINE DERIVATIVE; PRAZOSIN; PROPRANOLOL; RADIOLIGAND; SEROTONIN; SEROTONIN 1B RECEPTOR; SEROTONIN 2A RECEPTOR; SEROTONIN ANTAGONIST; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; URGOSEDIN; YOHIMBINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; CELL LINE; COMPETITIVE INHIBITION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DRUG EFFECT; DRUG EFFICACY; DRUG RECEPTOR BINDING; DRUG STRUCTURE; ENZYME INDUCTION; HYPOGLYCEMIA; HYPOTENSION; INFLAMMATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RADIOASSAY; RAT; RAT STRAIN; THORACIC AORTA; VASOCONSTRICTION;

ACUTE TOXICITY TESTS; ADMINISTRATION, ORAL; ADRENERGIC ALPHA-ANTAGONISTS; ANIMALS; AORTA, THORACIC; BENZENE DERIVATIVES; BLOOD GLUCOSE; CELL LINE; CYTOKINES; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG EVALUATION, PRECLINICAL; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HEART RATE; HYPOGLYCEMIA; HYPOTENSION; INFLAMMATION MEDIATORS; INJECTIONS, INTRAPERITONEAL; INJECTIONS, INTRAVENOUS; LIPOPOLYSACCHARIDES; MICE; MICE, INBRED ICR; MUSCLE CONTRACTION; MUSCLE, SMOOTH, VASCULAR; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; NOREPINEPHRINE; PIPERAZINES; PRODRUGS; RATS; RATS, WISTAR; SEROTONIN; SEROTONIN AGENTS;

EID: 4344629661     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.fjc.0000137155.63604.7a     Document Type: Article

References (43)

1. Bone RC. The sepsis syndrome. Definition and general approach to management. Clin Chest Med. 1996;17:175-181.
2. Vincent JL. Definition and pathogenesis of septic shock. Curr Top Microbiol. 1996;216:1-13.
3. Iwase M, Yokota M, Kitaichi K, et al. Cardiac functional and structural alterations induced by endotoxin in rats: importance of platelet-activating factor. Crit Care Med. 2001;29:609-617.
4. Teale DM, Atkinson AM. L-Canavanine restores blood pressure in a rat model of endotoxic shock. Eur J Pharmacol. 1994;271:87-92.
5. Chensue SW, Terebuh PD, Remick DG, et al. In vivo biologic and immunohistochemical analysis of interleukin-1 alpha, beta and tumor necrosis factor during experimental endotoxemia. Kinetics, Kupffer cell expression, and glucocorticoid effects. Am J Pathol. 1991;138:395-402.
6. Le J, Vilcek J. Biology of disease. Tumor necrosis factor and interleukin 1: cytokines with multiple overlapping biological activities. Lab Invest. 1987;56:234-248.
7. Luster MI, Germolec DR, Yoshida T, et al. Endotoxin-induced cytokine gene expression and excretion in the liver. Hepatology. 1994; 19:480-488.
8. Oguri S, Motegi K, lwakura Y, et al. Primary role of interleukin-1 alpha and interleukin-1 beta in lipopolysaccharide-induced hypoglycemia in mice. Clin Diagn Lab Immunol. 2002;9:1307-1312.
9. Crowley SR. The pathogenesis of septic shock. Heart Lung. 1996;25: 124-134.
10. Horn KD. Evolving strategies in the treatment of sepsis and systemic inflammatory response syndrome (SIRS). Q J Med. 1998;91:265-277.
11. Warren JB, Coughlan ML, Williams TJ. Endotoxin-induced vasodilatation in anaesthetized rat skin involves nitric oxide and prostaglandin synthesis. Br J Pharmacol. 1992;106:953-957.
12. Richardson BP, Engel G, Donatsch P, et al. Identification of serotonin M-receptor subtypes and their specific blockade by a new class of drugs. Nature. 1985;316:126-131.
13. Barnes PJ, Belvisi MG, Rogers DF. Modulation of neurogenic inflammation: novel approaches to inflammatory disease. Trends Pharmacol Sci. 1990;11:185-189.
14. Grubb BD, McQueen DS, Iggo A, et al. A study of 5-HT receptors associated with afferent nerves located in normal and inflamed rat ankle joints. Agents Actions. 1988;25:216-221.
15. Rueff A, Dray A. Pharmacological characterization of the effects of 5-hydroxytrypt-amine and different prostaglandins on peripheral sensory neurons in vitro. Agents Actions. 1993;38:C13-C15.
16. Mastronardi CA, Yu WH, McCann S. Lipopolysaccharide-induced tumor necrosis factor-alpha release is controlled by the central nervous system. Neuroimmunomodulation. 2001;9:148-156.
17. Szelenyi J, Kiss JP, Puskas E, et al. Opposite role of alpha2- and beta-adrenoceptors in the modulation of interleukin-10 production in endotoxaemic mice. Neuroreport. 2000;11:3565-3568.
18. Rouppe van der Voort C, Kavelaars A, vab de Pol M, et al. Noradrenaline induces phosphorylation of ERK-2 in human peripheral blood mononuclear cells after induction of alpha(1)-adrenergic receptors, J Neuroimmunol. 2000;108:82-91.
19. 3-adrenoceptor agonistic activity and free radical scavenging properties. Bioorg Med Chem. 1995;12:209-212.
20. Huang YC, Wu BN, Yeh JL, et al. A new aspect of view in synthesizing new type β-adrenoceptor blockers with ancillary antioxidant activities. Bioorg Med Chem. 2001;9:1739-1746.
21. 1-adrenoceptor antagonists derived from vanillin. Biochem Pharmacol. 1994;48:101-109.
22. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976;72:248-254.
23. Lo YC, Hsiao HC, Wu DC, et al. A novel capsaicin derivative VOA induced relaxation in rat mesenteric and aortic arteries: involvement of CGRP, NO, cGMP and endothelium-dependent activities. J Cardiovasc Pharmacol. 2003;42:511-520.
24. Litchfield JL, Wilcoxon F. A simplified method evaluating dose-effect experiments. J Pharmacol Exp Ther. 1949;96:99-113.
25. Schrott LM, Sweeney WA, Bodensteiner KE, et al. Late embryonic ritanserin exposure fails to alter normal responses to immune system stimulation in young chicks. Pharmacol Biochem Behav. 1999;64:81-88.
26. Altenburg AP, Martins MA, Silva A, et al. LPS-induced blood neutrophilia is inhibited by alpha 1-adrenoceptor antagonists: a role for catecholamines. J Leukoc Biol. 1997;61:689-694.
27. Mailman D. A role for abdominal vagal afferents in lipopolysaccharide- induced hypotension. Shock. 2002;18:177-181.
28. Fessler HE, Otterbein L, Chung HS, et al. Alpha-2 adrenoceptor blockade protects rats against lipopolysaccharide. Am J Respir Crit Care Med. 1996;154:1689-1693.
29. Bertini R, Garattini S, Delgado R, et al. Pharmacological activities of chlorpromazine involved in the inhibition of tumour necrosis factor production in vivo in mice. Immunology. 1993;79:217-219.
30. Altenburg SP, Paixao e Silva S, Ventura DG, et al. A role for adrenoceptors in the regulation of pleural neutrophilia induced by LPS. J Neuroimmunol. 2000;111:15-22.
31. Lynn WA, Noursadeghi M, Cohen J. Immunopathogenesis of severe sepsis. J Roy Coll Phys Lond. 2000;34:432-436.
32. Jacobi J. Pathophysiology of sepsis. Am J Health Syst Pharm. 2002;59: S3-S10.
33. Landry DW, Oliver JA. The pathogenesis of vasodilatory shock. N Engl J Med. 2001;345:588-595.
34. Höcherl K, Dreher F, Kurtz A, et al. Cyclooxygenase-2 inhibition attenuates lipopolysaccharides-induced cardiovascular failure. Hypertension. 2002;40:947-953.
35. 1A receptors during acute endotoxemia in rats. Am J Physiol Regul Integr Comp Physiol. 2002;282:R979-R984.
36. Bucher M, Taeger K. Endothelin-receptor gene-expression in rat endotoxemia. Intensive Care Med. 2002;28:642-647.
37. Wu CC, Chen SJ, Szabo C, et al. Aminoquanidine attenuates the delayed circulatory failure and improves survival in rodent models of endotoxic shock. Br J Pharmacol. 1995;114:1666-1672.
38. Lin HC, Wan FJ, Kang BH, et al. Systemic administration of lipopolysaccharide induces release of nitric oxide and glutamate and c-fos expression in the nucleus tractus solitarii of rats. Hypertension. 1999;33:1218-1224.
39. Chen YC, Shenm SC, Chen LG, et al. Wogonin, baicalin, and baicalein inhibition of inducible nitric oxide synthase and cyclooxygenase-2 gene expression induced by nitric oxide synthase inhibitor and lipopolysaccharide. Biochem Pharmacol. 2001;61:1417-1427.
40. Smith WL, DeWitt DL, Garavito RM. Cyclooxygenases: structural, cellular, and molecular biology. Anna Rev Biochem. 2000;69:145-182.
41. Crouser ED, Dorinsky PM. Metabolic consequences of sepsis: correlation with altered intracellular calcium homeostasis. Clin Chest Med. 1996;17: 249-261.
42. Horton RA, Knowles RG, Titheradge MA. Endotoxin causes reciprocal changes in hepatic nitric oxide synthesis, gluconeogenesis, and flux through phosphoenolpyruvate carboxykinase. Biochem Biophys Res Commun. 1994;204:659-665.
43. Endo Y. Parallel relationship between the increase in serotonin in the liver and the hypoglycaemia induced in mice by interleukin-1 and tumour necrosis factor. Immunol Lett. 1991;27:75-79.